ALIVUS LIFE SCIENCES LTD : ACQUIRES 76% STAKE IN IQGEN-X PHARMA PRIVATE LIMITED

• Alivus Life Sciences Limited Board of Directors approved the share purchase agreement to acquire 76% stake in IQGEN-X Pharma Private Limited for an aggregate consideration of INR 9.12 crores, subject to adjustment. • The target company, IQGEN-X Pharma Private Limited, has an authorized share capital of ₹2,00,00,000 divided into 20,00,000 equity shares of ₹10/- each and reported a turnover of INR 348 Lacs for the financial year ended March 31, 2026. • The acquisition is not a related party transaction and no promoter has any interest in the entity being acquired. • IQGEN-X Pharma Private Limited provides formulation development for Oral Solids, Sterile Injectables, and Ophthalmic solutions. • The indicative time period for completion of the acquisition is December 6, 2026, or as agreed by parties, subject to fulfillment of conditions precedent.

Alivus Life Sciences Limited

Open attachment

← Back to feed